Metabolic and Bariatric Surgery ·
The systematic review and meta-analysis investigated gastroesophageal reflux disease (GERD) as a major concern following one anastomosis gastric bypass (OAGB). The analysis of 40 studies involving 17,299 patients revealed that 2% of patients experienced GERD after OAGB, with reflux rates six times higher in revisional OAGB compared to primary OAGB. Medical and surgical treatments were used in 60% and 41% of patients, respectively, with estimated success rates of 85% and 100%.
Summaries are written to help you decide what to read. They do not replace the full paper.
Free · 5 minutes a day
Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.
More in Metabolic and Bariatric Surgery
Endoscopic sleeve gastroplasty (ESG) provides moderate weight loss with a lower risk of complications compared to laparoscopic sleeve gastrectomy (LSG), making it a viable option for patients, particularly those with existing gastro-esophageal reflux disease (GERD).
A new calculator predicts type 2 diabetes remission outcomes for patients post-metabolic surgery, improving patient selection.
Endoscopic duodenal-jejunal bypass liner may significantly improve glycemic control and weight loss in patients with poorly controlled type 2 diabetes and obesity.
